comparemela.com

Latest Breaking News On - Evolut low risk trial - Page 2 : comparemela.com

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

TAVI benefits were attenuated and mortality trended higher in PARTNER 3 at 5 years. For Evolut, TAVI maintained an edge.

Boston
Massachusetts
United-states
New-york
Houston
Texas
Gilbert-tang
Pinak-shah
David-cohen
Michael-reardon
Edwards-lifesciences
Kendra-grubb

TAVR continues to be comparable to surgery in patients at low surgical risk

TAVR continues to be comparable to surgery in patients at low surgical risk
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Edwards-lifesciences
Michaelj-reardon
Cardiovascular-data-science-center
Weill-cornell-medical-college
Academic-institute
Cardiovascular-research-foundation
Medtronic
Journal-of-the-american-college-cardiology
Cardiovascular-research
Research-institute-at-houston-methodist
Evolut-low-risk-trial
New-england-journal

TAVR beneficial in patients at low surgical risk, but data on long-term durability awaited

TAVR beneficial in patients at low surgical risk, but data on long-term durability awaited
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Boston
Massachusetts
United-states
Byerik-swain
Edwards-lifesciences
Vinodh-thourani
Richard-smith
Boston-scientific
Medtronic
Healio-interviews
Abbott-vascular
New-england-journal

Initial benefit of TAVR remains consistent over the first three years among patients at low surgical risk

The number of deaths and disabling strokes among patients at low surgical risk who were treated with transcatheter aortic valve replacement (TAVR) remained lower at three years, but not significantly lower, following the TAVR procedure compared with patients who received conventional surgical aortic valve replacement (SAVR), according to new data being presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology.

New-zealand
Australia
Japan
United-states
Netherlands
New-haven
Connecticut
Canada
France
Yale-university
American
Johnk-forrest

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.